After a quick trial revamp, FDA lifts its clinical hold on Concert’s hair-loss drug
Less than two months after Concert Pharmaceuticals $CNCE rattled investors with the news that the FDA had placed a clinical hold on its drug CTP …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
